SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-113518
Filing Date
2024-11-01
Accepted
2024-11-01 16:31:07
Documents
1
Period of Report
2024-10-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2427268-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2427268-2_4seq1.xml 4 4036
  Complete submission text file 0001104659-24-113518.txt   5727
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE NEWTON MA 02459
Business Address
Cheng Sohanya Roshan (Reporting) CIK: 0001865796 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36296 | Film No.: 241419479